SPARC and neoplasm: Indeed, in ovarian cancer, SPARC has been shown to sensitize tumor cells to cisplatin therapy [24] and to enhance apoptosis and potentiate sensitivity to the chemotherapeutic agent 5-fluorouracil in colorectal cancer [23].